Compreendendo que nas últimas décadas os psicobióticos, uma nova classe de probióticos, direcionaram muitos pesquisadores a se concentrarem no estudo dos mesmos em relação ao seu potencial terapêutico para transtornos psíquicos, o presente estudo compilou dados da literatura científica a respeito das recentes descobertas relacionadas aos psicobióticos como uma potencial alternativa para o tratamento da ansiedade. Para tal foi realizada uma revisão integrativa de literatura, por meio de consultas a artigos publicados nos últimos seis anos por meio das bases de dados PubMed/MEDLINE e SciELO, utilizando os seguintes descritores:"Probiotics and anxiety", "Psycobiotcs and anxiety", publicados na íntegra em inglês. Totalizando 267 estudos encontrados, dos quais meramente 14 artigos foram elegíveis. A princípio foram discutidos os benefícios gerados pelos psicobióticos para a saúde mental, bem como sua importância na compreensão dos mecanismos envolvidos na relação do eixo cérebro-microbioma-intestino quanto aos transtornos psicológicos, especialmente a ansiedade. Por meio da análise dos estudos pré-clínicos e clínicos selecionados, foi possível identificar cepas de probióticos que apresentam maior potencial a candidatos psicobióticos, com ênfase no tratamento da ansiedade. De forma geral, os estudos demonstraram a eficácia dos psicobióticos, os quais foram capazes de atenuar os sintomas causados pelos quadros de ansiedade, melhorando funções do sistema nervoso central, com baixa ocorrência ou ausência de efeitos adversos. Assim, futuramente podem compor uma nova abordagem terapêutica para o tratamento dos sintomas de ansiedade e outras comorbidades psiquiátricas.
Neuropathic pain (NP) is the most prevalent and debilitating form of chronic pain, caused by injuries or diseases of the somatosensory system. Since current first-line treatments only provide poor symptomatic relief, the search for new therapeutic strategies for managing NP is an active field of investigation. Multiple mechanisms contribute to the genesis and maintenance of NP, including damage caused by oxidative stress. The naturally occurring antioxidant alpha-lipoic acid (ALA) is a promising therapeutic agent for the management of NP. Several pre-clinical in vitro and in vivo studies as well as clinical trials demonstrate the analgesic potential of ALA in the management of NP. The beneficial biological activities of ALA are reflected in the various patents for the development of ALA-based innovative products. This review demonstrates the therapeutic potential of ALA in the management of NP by discussing its analgesic effects by multiple antioxidant mechanisms as well as the use of patented ALA-based products and how technological approaches have been applied to enhance ALA’s pharmacological properties.
The high prevalence of anxiety disorders associated with pharmacotherapy side effects have motivated the search for new pharmacological agents. Species from Citrus genus, such as Citrus limon (sicilian lemon), have been used in folk medicine as a potential therapy to minimize emotional disorders. In order to searching for new effective treatments with fewer side effects, the present study evaluated the anxiolytic mechanism of action and the hypnotic-sedative activity from the Citrus limon fruit's peels essential oil (CLEO). Adults male Swiss mice were submitted to barbiturate-induced sleep test; elevated plus-maze (EPM) and light-dark box (LDB) (evaluation of the mechanism of action); rotarod; and catalepsy tests. CLEO oral treatment decreased latency and increased the sleep total time; moreover it induced in animals an increased the number of entries and percentage of time spent into open arms of the EPM; an increased the number of transitions and the percentage of time into light compartment in the LDB; which were only antagonized by flumazenil pretreatment, with no injury at motor function. Thus, results suggest that CLEO treatment induced an anxiolytic behavior suggestively modulated by the benzodiazepine binding site of the GABAA receptor or by an increase of GABAergic neurotransmission, without cause impairment in the motor coordination. HIGHLIGHTS Essential oils from Citrus genus induce anxiolytic-like effects; Citrus limon essential oil acts as hypnotic-sedative and anxiolytic drug; GABAergic pathway is suggestively related to Citrus limon essential oil action; No motor impairment was observed with Citrus limon essential oil. 2 Viana, M.D.M..; et al.
In view of the traditional use of Tabebuia aurea for treating pain and inflammation, the antinociceptive pharmacological potential of T. aurea ethanolic extracts (TAEE) was investigated through in vivo experimental models. First, the MTT assay was conducted to determine the potential cytotoxicity of the TAEEs. Afterwards, the acetic acid-induced writhing test and the formalin-, and glutamate-induced nociception tests were performed on Swiss adult mice treated with TAEEs (100 and 200 mg/kg doses, p.o.), or saline solution (control groups, 10mL/kg, p.o.), or standard drugs: dipyrone 40 mg/kg (p.o.), and morphine 5,7 mg/kg (i.p). In the MTT assay, none of the tested concentrations demonstrated signals of cytotoxicity. In the in vivo experimental models of acetic acid-induced writhing and glutamate-induced nociception, all TAEEs doses were able to statistically reduce the nociceptive response. However, the TAEEs did not show significant decrease in the amount of time that the animals spent licking the stimulated paw in the neurogenic phase of formalin-induced nociception test, differently of what was observed in the inflammatory phase. The results showed that T. aurea species induce an antinociceptive effect in rodents, which encourages the study of new drugs and contributes to the research on natural products.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.